Keros Therapeutics, Inc. Profile Avatar - Palmy Investing

Keros Therapeutics, Inc.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. T…

Biotechnology
US, Lexington [HQ]

News

Theses · Events · Sentiments
End of KROS's Analysis
CIK: 1664710 CUSIP: 492327101 ISIN: US4923271013 LEI: - UEI: -
Secondary Listings
KROS has no secondary listings inside our databases.